VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

852

Enrollment

INDUSTRY

Sponsor class

Conditions

Clostridium Difficile
Clostridium Difficile Infections
Clostridium Difficile Infection Recurrence
Clostridioides Difficile Infection
Clostridioides Difficile Infection Recurrence
CDI
C. Diff Infection
Recurrent Clostridium Difficile Infection
C.Difficile Diarrhea
Diarrhea Infectious

Interventions

BIOLOGICAL: VE303
BIOLOGICAL: Placebo

Sponsor

Vedanta Biosciences, Inc.